News

Breaking News

Entertainment

Movies & Series

Music

Science & Technology

Sport

Business & Money

Education & Personal Development

Life

Culture & Art

Hobbies

News

Entertainment

Science & Technology

Sport

Business & Money

Education & Personal Development

Life

Culture & Art

Hobbies

home
›
Hospital Pharmacy Europe
›
Health

Hospital Pharmacy Europe - Health

6 | Follower

Hospital Pharmacy Europe

26.04.2024

Three indications of NSCLC covered by EC approval of tislelizumab - Hospital Pharmacy EuropeHospital Pharmacy Europe

Tislelizumab has been approved by the European Commission for use in patients with treatment-naive and relapsed non-small cell lung cancer.

Hospital Pharmacy Europe

26.04.2024

RPS updates patient safety professional standards to reflect pharmacy evolution - Hospital Pharmacy EuropeHospital Pharmacy Europe

The RPS has published updated patient safety professional standards to reflect legislative, developments since their 2016 iteration.

Hospital Pharmacy Europe

25.04.2024

Antipsychotic use in dementia linked to more adverse outcomes than thought, study finds - Hospital Pharmacy EuropeHospital Pharmacy Europe

Use of antipsychotic medications in patients with dementia is associated with a much wider range of serious harms than previously thought.

Hospital Pharmacy Europe

24.04.2024

Cilta-cel approved by EC as second-line R/R multiple myeloma treatment - Hospital Pharmacy EuropeHospital Pharmacy Europe

Cilta-cel has been approved by the European Commission for use in the treatment of eligible patients with multiple myeloma.

Hospital Pharmacy Europe

24.04.2024

Semaglutide beneficial in patients with type 2 diabetes and obesity-related heart failure - Hospital Pharmacy EuropeHospital Pharmacy Europe

Semaglutide could be beneficial in helping to treat patients with type 2 diabetes and obesity-related heart failure, a study has shown.

Hospital Pharmacy Europe

24.04.2024

New tool for calculating carbon footprint of medicines launched - Hospital Pharmacy EuropeHospital Pharmacy Europe

A free tool that calculates the per-dose carbon footprint of medicines and indicates a carbon footprint rating has launched in the UK.

Hospital Pharmacy Europe

24.04.2024

Fourth indication for bimekizumab as EC approves drug for hidradenitis suppurativa - Hospital Pharmacy EuropeHospital Pharmacy Europe

Bimekizumab has been granted marketing authorisation by the European Commission for active moderate-to-severe hidradenitis suppurativa.

Hospital Pharmacy Europe

17.04.2024

Tisagenlecleucel recommended for routine NHS rollout to treat R/R B-cell ALL - Hospital Pharmacy EuropeHospital Pharmacy Europe

The CAR T-cell therapy tisagenlecleucel has been recommended for routine rollout on the NHS for R/R B-cell acute lymphoblastic leukaemia.

Hospital Pharmacy Europe

16.04.2024

Lixisenatide shows potential in slowing Parkinson’s disease progression - Hospital Pharmacy EuropeHospital Pharmacy Europe

The glucagon-like peptide 1 receptor agonist lixisenatide may slow the progression of Parkinson’s disease symptoms, research suggests.

Hospital Pharmacy Europe

16.04.2024

No evidence of causal link between GLP-1 receptor agonists and suicide, says PRAC - Hospital Pharmacy EuropeHospital Pharmacy Europe

Available evidence does not support a causal association between GLP-1 receptor agonists and suicidal thoughts, the PRAC has concluded.

Hospital Pharmacy Europe

16.04.2024

Some progestogen medicines associated with increased risk of meningioma, say researchers - Hospital Pharmacy EuropeHospital Pharmacy Europe

Some progestogen medicines have been linked to an increased risk of intracranial meningioma in a large study of French women.

Hospital Pharmacy Europe

13.04.2024

Atogepant recommended by NICE as first oral drug for chronic and episodic migraine prophylaxis - Hospital Pharmacy EuropeHospital Pharmacy Europe

Atogepant, the first oral drug for migraine prophylaxis where other treatments have failed should be available on the NHS, says NICE.

Hospital Pharmacy Europe

13.04.2024

In conversation with consultant pharmacist in cardiology Dr Rani Khatib - Hospital Pharmacy EuropeHospital Pharmacy Europe

Consultant pharmacist Dr Rani Khatib discusses best-practice approaches and the multidisciplinary team‘s collaborative power in cardiology.

Hospital Pharmacy Europe

12.04.2024

Chief pharmacist role should be mandatory for hospitals, RPS says - Hospital Pharmacy EuropeHospital Pharmacy Europe

Having a chief pharmacist in a hospital should not be optional, the RPS has said in its consultation response to the GPhC.

Hospital Pharmacy Europe

12.04.2024

Clinical Excellence in Respiratory Care returns with latest event for the MDT - Hospital Pharmacy EuropeHospital Pharmacy Europe

Registration is open for the Clinical Excellence in Respiratory Care event for the multidisciplinary team exploring innovations in the field.

Hospital Pharmacy Europe

11.04.2024

Gráinne d’Ancona on the expanding role of specialist pharmacists in multidisciplinary respiratory teams - Hospital Pharmacy EuropeHospital Pharmacy Europe

Consultant pharmacist Gráinne d’Ancona shares insights into pharmacists’ pivotal role in the respiratory medicine multidisciplinary team.

Hospital Pharmacy Europe

05.04.2024

GPhC issues advice on supporting children and young people with gender identity issues - Hospital Pharmacy EuropeHospital Pharmacy Europe

GPhC is encouraging pharmacists to signpost children and young people experiencing gender identity issues to appropriate support services.

Hospital Pharmacy Europe

05.04.2024

Cladribine indication expanded by MHRA to include active relapsing MS - Hospital Pharmacy EuropeHospital Pharmacy Europe

Cladribine tablets have been granted a label extension by the MHRA to expand access for active relapsing MS.

Hospital Pharmacy Europe

03.04.2024

Aripiprazole once-every-two-months long-acting injectable gains EU approval for schizophrenia - Hospital Pharmacy EuropeHospital Pharmacy Europe

The once-every-two-months long-acting injectable aripiprazole 960 mg has been approved by the EC for maintenance treatment of schizophrenia.

Hospital Pharmacy Europe

29.03.2024

FIP announces theme for World Pharmacists Day 2024 - Hospital Pharmacy EuropeHospital Pharmacy Europe

The theme of World Pharmacists Day 2024 on 25 September will be ‘Pharmacists: meeting global health needs’, FIP has announced.

Hospital Pharmacy Europe

29.03.2024

András Süle: Reinforcing hospital pharmacists as a core part of frontline patient care - Hospital Pharmacy EuropeHospital Pharmacy Europe

EAHP president András Süle calls for the self-advocacy of hospital pharmacists to reinforce their position as key to frontline healthcare.

Hospital Pharmacy Europe

28.03.2024

Scotland’s first consultant pharmacist appointed to support cancer outcomes and survival - Hospital Pharmacy EuropeHospital Pharmacy Europe

Scotland’s first consultant pharmacist has been appointed to provide clinical leadership and support the West of Scotland Cancer Network.

Hospital Pharmacy Europe

27.03.2024

Aztreonam-avibactam receives positive CHMP opinion for multidrug-resistant infections - Hospital Pharmacy EuropeHospital Pharmacy Europe

The antibiotic aztreonam-avibactam has received a positive opinion from the CHMP to treat multidrug-resistant infections.

Hospital Pharmacy Europe

27.03.2024

Rheumatoid arthritis progression halted in high-risk patients with abatacept use - Hospital Pharmacy EuropeHospital Pharmacy Europe

Abatacept can alleviate clinical symptoms in rheumatoid arthritis and limit its onset in high-risk patients, a new trial shows.

Hospital Pharmacy Europe

27.03.2024

Penicillin allergy labels can be safely removed for most patients, study suggests - Hospital Pharmacy EuropeHospital Pharmacy Europe

It is likely to be safe for penicillin allergy labels to be removed for most low-risk patients, a study has found.

Hospital Pharmacy Europe

22.03.2024

3D printing and personalised medicines: embracing innovative technologies - Hospital Pharmacy EuropeHospital Pharmacy Europe

Pharmacist Ian Soulairol discusses how 3d printing technology is evolving and what it means for clinical practice now and in the future.

Hospital Pharmacy Europe

15.03.2024

Etrasimod receives green light from MHRA and NICE for ulcerative colitis - Hospital Pharmacy EuropeHospital Pharmacy Europe

Etrasimod has been approved by the MHRA and recommended by NICE for treating eligible patients with ulcerative colitis.

Hospital Pharmacy Europe

15.03.2024

NICE recommends dostarlimab as first-line combination treatment for endometrial cancer - Hospital Pharmacy EuropeHospital Pharmacy Europe

Dostarlimab has been recommended by NICE for use in combination with chemotherapy for eligible patients with endometrial cancer.

Hospital Pharmacy Europe

15.03.2024

Medicines shortages investigation to be launched by the RPS - Hospital Pharmacy EuropeHospital Pharmacy Europe

A new project to investigate the causes of medicines shortages and help reduce their impact pharmacy practice is to be launched by the RPS.

Hospital Pharmacy Europe

14.03.2024

Positive CHMP opinion for cilta-cel as second-line R/R multiple myeloma treatment - Hospital Pharmacy EuropeHospital Pharmacy Europe

Ciltacabtagene autoleucel has received a positive opinion from the CHMP for use in the treatment of eligible patients with multiple myeloma.

Hospital Pharmacy Europe

14.03.2024

Tailored prostate cancer treatments edge closer as AI study reveals two distinct subtypes - Hospital Pharmacy EuropeHospital Pharmacy Europe

Prostate tumours evolve in two disease subtypes, according to a new AI study, which may lead to better diagnosis and tailored treatments.

Hospital Pharmacy Europe

13.03.2024

Simple treatment strategies could reduce high risk of myocardial infarction in kidney failure - Hospital Pharmacy EuropeHospital Pharmacy Europe

Kidney failure patients are at ‘an unacceptably high risk’ of myocardial infarction and stroke but simple treatment strategies could help.

Hospital Pharmacy Europe

13.03.2024

Research grant for pharmacist specialisation and advanced practice topics opens for applications - Hospital Pharmacy EuropeHospital Pharmacy Europe

The FIP Foundation and the BPS are inviting proposals for a collaborative research grant in the field of pharmacist certification.

Hospital Pharmacy Europe

08.03.2024

Poorly controlled asthma causes substantial greenhouse gas emissions, study reveals - Hospital Pharmacy EuropeHospital Pharmacy Europe

Poorly controlled asthma contributes eight times more excess greenhouse gas emissions than those with well-managed asthma, research has found.

Hospital Pharmacy Europe

08.03.2024

Early treatment of Crohn’s disease redefined and outcomes improved in new study - Hospital Pharmacy EuropeHospital Pharmacy Europe

Top-down treatment substantially improves outcomes for newly diagnosed Crohn’s disease compared with accelerated step-up therapy.

Hospital Pharmacy Europe

08.03.2024

Research finds many oncology drugs have ‘little or no added benefit’ - Hospital Pharmacy EuropeHospital Pharmacy Europe

Many oncology drugs approved by the EMA between 2005 and 2020 provide ‘little or no added benefit’ for patients, according to new research.

Hospital Pharmacy Europe

08.03.2024

Using pharmacogenomics to improve medicines use after myocardial infarction - Hospital Pharmacy EuropeHospital Pharmacy Europe

Dr Emma Magavern discusses her research into clopidogrel use after myocardial infarction and the value of clinicians adopting genetic testing.

Hospital Pharmacy Europe

08.03.2024

New study challenges aspirin guidelines for patients at risk of atherosclerotic cardiovascular disease - Hospital Pharmacy EuropeHospital Pharmacy Europe

A new study challenges the ‘one size fits all’ approach to current aspirin guidelines for primary prevention of ASCVD.

Hospital Pharmacy Europe

01.03.2024

Olive oil-derived drug shows early promise for patients with glioblastoma - Hospital Pharmacy EuropeHospital Pharmacy Europe

A first-in-class drug derived from olive oil has shown early promise in patients with an advanced form of brain cancer.

Hospital Pharmacy Europe

01.03.2024

Vast majority of hospital pharmacists at risk of burnout, new RPS wellbeing survey shows - Hospital Pharmacy EuropeHospital Pharmacy Europe

Almost nine in 10 hospital pharmacists are at high risk of burnout, according to the latest RPS workforce and wellbeing survey.

home›Hospital Pharmacy Europe›Health

Hospital Pharmacy Europe - Health

Three indications of NSCLC covered by EC approval of tislelizumab - Hospital Pharmacy EuropeHospital Pharmacy Europe

RPS updates patient safety professional standards to reflect pharmacy evolution - Hospital Pharmacy EuropeHospital Pharmacy Europe

Antipsychotic use in dementia linked to more adverse outcomes than thought, study finds - Hospital Pharmacy EuropeHospital Pharmacy Europe

Cilta-cel approved by EC as second-line R/R multiple myeloma treatment - Hospital Pharmacy EuropeHospital Pharmacy Europe

Semaglutide beneficial in patients with type 2 diabetes and obesity-related heart failure - Hospital Pharmacy EuropeHospital Pharmacy Europe

New tool for calculating carbon footprint of medicines launched - Hospital Pharmacy EuropeHospital Pharmacy Europe

Fourth indication for bimekizumab as EC approves drug for hidradenitis suppurativa - Hospital Pharmacy EuropeHospital Pharmacy Europe

Tisagenlecleucel recommended for routine NHS rollout to treat R/R B-cell ALL - Hospital Pharmacy EuropeHospital Pharmacy Europe

Lixisenatide shows potential in slowing Parkinson’s disease progression - Hospital Pharmacy EuropeHospital Pharmacy Europe

No evidence of causal link between GLP-1 receptor agonists and suicide, says PRAC - Hospital Pharmacy EuropeHospital Pharmacy Europe

Some progestogen medicines associated with increased risk of meningioma, say researchers - Hospital Pharmacy EuropeHospital Pharmacy Europe

Atogepant recommended by NICE as first oral drug for chronic and episodic migraine prophylaxis - Hospital Pharmacy EuropeHospital Pharmacy Europe

In conversation with consultant pharmacist in cardiology Dr Rani Khatib - Hospital Pharmacy EuropeHospital Pharmacy Europe

Chief pharmacist role should be mandatory for hospitals, RPS says - Hospital Pharmacy EuropeHospital Pharmacy Europe

Clinical Excellence in Respiratory Care returns with latest event for the MDT - Hospital Pharmacy EuropeHospital Pharmacy Europe

Gráinne d’Ancona on the expanding role of specialist pharmacists in multidisciplinary respiratory teams - Hospital Pharmacy EuropeHospital Pharmacy Europe

GPhC issues advice on supporting children and young people with gender identity issues - Hospital Pharmacy EuropeHospital Pharmacy Europe

Cladribine indication expanded by MHRA to include active relapsing MS - Hospital Pharmacy EuropeHospital Pharmacy Europe

Aripiprazole once-every-two-months long-acting injectable gains EU approval for schizophrenia - Hospital Pharmacy EuropeHospital Pharmacy Europe

FIP announces theme for World Pharmacists Day 2024 - Hospital Pharmacy EuropeHospital Pharmacy Europe

András Süle: Reinforcing hospital pharmacists as a core part of frontline patient care - Hospital Pharmacy EuropeHospital Pharmacy Europe

Scotland’s first consultant pharmacist appointed to support cancer outcomes and survival - Hospital Pharmacy EuropeHospital Pharmacy Europe

Aztreonam-avibactam receives positive CHMP opinion for multidrug-resistant infections - Hospital Pharmacy EuropeHospital Pharmacy Europe

Rheumatoid arthritis progression halted in high-risk patients with abatacept use - Hospital Pharmacy EuropeHospital Pharmacy Europe

Penicillin allergy labels can be safely removed for most patients, study suggests - Hospital Pharmacy EuropeHospital Pharmacy Europe

3D printing and personalised medicines: embracing innovative technologies - Hospital Pharmacy EuropeHospital Pharmacy Europe

Etrasimod receives green light from MHRA and NICE for ulcerative colitis - Hospital Pharmacy EuropeHospital Pharmacy Europe

NICE recommends dostarlimab as first-line combination treatment for endometrial cancer - Hospital Pharmacy EuropeHospital Pharmacy Europe

Medicines shortages investigation to be launched by the RPS - Hospital Pharmacy EuropeHospital Pharmacy Europe

Positive CHMP opinion for cilta-cel as second-line R/R multiple myeloma treatment - Hospital Pharmacy EuropeHospital Pharmacy Europe

Tailored prostate cancer treatments edge closer as AI study reveals two distinct subtypes - Hospital Pharmacy EuropeHospital Pharmacy Europe

Simple treatment strategies could reduce high risk of myocardial infarction in kidney failure - Hospital Pharmacy EuropeHospital Pharmacy Europe

Research grant for pharmacist specialisation and advanced practice topics opens for applications - Hospital Pharmacy EuropeHospital Pharmacy Europe

Poorly controlled asthma causes substantial greenhouse gas emissions, study reveals - Hospital Pharmacy EuropeHospital Pharmacy Europe

Early treatment of Crohn’s disease redefined and outcomes improved in new study - Hospital Pharmacy EuropeHospital Pharmacy Europe

Research finds many oncology drugs have ‘little or no added benefit’ - Hospital Pharmacy EuropeHospital Pharmacy Europe

Using pharmacogenomics to improve medicines use after myocardial infarction - Hospital Pharmacy EuropeHospital Pharmacy Europe

New study challenges aspirin guidelines for patients at risk of atherosclerotic cardiovascular disease - Hospital Pharmacy EuropeHospital Pharmacy Europe

Olive oil-derived drug shows early promise for patients with glioblastoma - Hospital Pharmacy EuropeHospital Pharmacy Europe

Vast majority of hospital pharmacists at risk of burnout, new RPS wellbeing survey shows - Hospital Pharmacy EuropeHospital Pharmacy Europe

home
›
Hospital Pharmacy Europe
›
Health